ITCI Intra-Cellular Therapies
- 83.450
- -0.690-0.82%
- 83.450
- 0.0000.00%
Intra-Cellular Therapies所有資訊
Intra-Cellular Therapies | 4：持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股變動聲明-高管 Halstead Michael
Intra-Cellular Therapies | SC 13G/A：超過5%持股股東披露文件(修正)-FMR LLC(10.525%),Abigail P. Johnson(10.525%)
Intra-Cellular Therapies | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(5.9%)
Intra-Cellular Therapies | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(5.9%)
Intra-Cellular Therapies | 4：持股變動聲明-董事 RIGGS RORY B
Intra-Cellular Therapies | SC 13G：超過5%持股股東披露文件-JPMORGAN CHASE & CO.(5.0%)
Intra-Cellular Therapies | 4：持股變動聲明-董事 RIGGS RORY B
Intra-Cellular Therapies | 4：持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股變動聲明-高管 Neumann Mark
Intra-Cellular Therapies | 4：持股變動聲明-高管 Narula Sanjeev
Intra-Cellular Therapies | 3：首次持股聲明-高管 Narula Sanjeev
Intra-Cellular Therapies | 4：持股變動聲明-董事 VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4：持股變動聲明-董事 RIGGS RORY B
Intra-Cellular Therapies | 4：持股變動聲明-董事 VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4：持股變動聲明-董事 Salas Eduardo Rene
Intra-Cellular Therapies | 4：持股變動聲明-董事 MARCUS JOEL S
Intra-Cellular Therapies | 4：持股變動聲明-董事 RIGGS RORY B
暫無數據